Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Fecal Microbiota Transplantation Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Fecal Microbiota Transplantation. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Fecal Microbiota Transplantation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 / Phase 3 is the largest group at 50% (1 studies); the largest phase groups are Phase 2 / Phase 3: 1, Phase 2: 1.

Research is led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1), Guangzhou First People's Hospital (1), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo capsules (other, 2 trials), followed by Fecal Microbial transplant, Fecal microbiota transplantation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Fecal Microbiota Transplantation trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05790356

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

This clinical trial will investigate the effects of capsules containing stool from healthy donors, called fecal microbial transplant (FMT), in rheumatoid arthritis patients.

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sEnrolling: 301 location
RECRUITINGPhase 2 / Phase 3NCT03804931

Fecal Microbiota Transplantation for Ulcerative Colitis

Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal...

Sponsor: Guangzhou First People's HospitalEnrolling: 1201 location
RECRUITINGPhase 2NCT05821010

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

The goal of this clinical trial is to investigate the therapeutic potential of A. soehngenii and pasteurized A. muciniphila combined with B. animalis subsp. lactis and...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 481 location

Frequently Asked Questions

There are currently 3 clinical trials for Fecal Microbiota Transplantation, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Fecal Microbiota Transplantation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Fecal Microbiota Transplantation, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.